We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Point-of-Care Testing Market Is Growing

By HospiMedica staff writers
Posted on 22 Dec 2006
The need to diagnose and treat patients immediately is boosting the growth of the point-of-care testing (POCT) market in the United States and elsewhere.

According to a new study by Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm, this market generated revenues of U.S.$1.3 billion in the United States alone in 2005, and is estimated to reach $2.4 billion by 2012.

"Point-of-care testing is becoming the standard of practice for an increasing number of diagnostics in areas such as glucose, blood gas and electrolytes, cholesterol, infectious diseases, and others,” noted Frost & Sullivan Research Analyst Kevin Leong. More...
"The speed and convenience of testing at the point-of-care is resulting in rapid medical intervention and improved patient outcomes.”

Immediate diagnosis and treatment increase patient satisfaction, avoid inefficiencies in administrative follow-ups, and minimize delays in treatments that could otherwise result in adverse complications and costly consequences. These benefits make it very attractive for medical professionals to adopt POCT and, in turn, fuel market growth.

However, the majority of diagnostic tests continue to be performed in centralized laboratories due to their long established use in medical practice. Physicians are primarily concerned with patient care, and rely on trained clinicians to perform quality diagnostics in laboratories. There remains a perception that point-of-care testing is inaccurate and inferior to laboratory analyzers.

Market participants need to emphasize the impact of rapid diagnostics for improved patient outcomes. Conducting compelling studies to support the accuracy and clinical utility of POCT will increase the comfort levels of healthcare practitioners with such methods. This also requires that POCT devices be user-friendly, ensuring quicker learning for immediate usage and adoption.



Related Links:
Frost & Sullivan

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Infant Resuscitator
Easypuff
Medical Monitor
VITALMAX 4100SL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.